InvestSMART

Australian Clinical Labs Limited (ASX: ACL) - Announcements

- Current share price for ACL : $2.860

ASX company news and announcements for Australian Clinical Labs Limited (ACL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Australian Clinical Labs Limited (ACL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Australian Clinical Labs Limited (ACL), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Australian Clinical Labs Limited (ACL)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$533 ACL 31 December 2020 financial statements 14 May 2021 9:21AM $0.011 $2.860 risen by 25,900%
$533 Clinical Laboratories 30 June 2020 financial statements 14 May 2021 9:19AM $0.011 $2.860 risen by 25,900%
$533 Clinical Laboratories 30 June 2019 financial statements 14 May 2021 9:19AM $0.011 $2.860 risen by 25,900%
$533 Clinical Laboratories 30 June 2018 financial statements 14 May 2021 9:18AM $0.011 $2.860 risen by 25,900%
$533 Constitution 14 May 2021 9:16AM $0.011 $2.860 risen by 25,900%
$533 Prospectus 14 May 2021 9:16AM $0.011 $2.860 risen by 25,900%
$533 Appendix 1A and information form and checklist 14 May 2021 9:14AM $0.011 $2.860 risen by 25,900%
$533 Admission to Official List 14 May 2021 9:10AM $0.011 $2.860 risen by 25,900%
$533 Admission and commencement of quotation 12 May 2021 3:48PM $0.011 $2.860 risen by 25,900%
$533 Final Director's Interest Notices x2 8 Oct 2019 12:24PM $0.011 $2.860 risen by 25,900%
$533 Change of Director's Interest Notice 8 Oct 2019 12:23PM $0.011 $2.860 risen by 25,900%
$533 Initial Director's Interest Notice x3 8 Oct 2019 12:20PM $0.011 $2.860 risen by 25,900%
$533 Becoming a substantial holder 4 Oct 2019 5:35PM $0.011 $2.860 risen by 25,900%
$533 Becoming a substantial holder 4 Oct 2019 5:34PM $0.011 $2.860 risen by 25,900%
$533 Becoming a substantial holder 4 Oct 2019 5:31PM $0.011 $2.860 risen by 25,900%
$533 Becoming a substantial holder 4 Oct 2019 5:31PM $0.011 $2.860 risen by 25,900%
$533 Appendix 3B 3 Oct 2019 3:59PM $0.011 $2.860 risen by 25,900%
$533 Completion of Acquisition and Capital Raising 3 Oct 2019 9:16AM $0.011 $2.860 risen by 25,900%
$533 Completion of Share Consolidation 27 Sep 2019 8:49AM $0.011 $2.860 risen by 25,900%
$533 Replacement Prospectus 16 Sep 2019 4:13PM $0.011 $2.860 risen by 25,900%
$533 Results of Annual General Meeting 16 Sep 2019 1:57PM $0.011 $2.860 risen by 25,900%
$533 Consolidation/Split - ACL 13 Sep 2019 4:05PM $0.011 $2.860 risen by 25,900%
$533 Notice of AGM, Independent Expert's Report & Proxy Form 12 Aug 2019 9:51AM $0.011 $2.860 risen by 25,900%
$533 Appendix 4G and Corporate Governance Statement 1 Aug 2019 4:51PM $0.011 $2.860 risen by 25,900%
$533 Appendix 4E and 2019 Annual Report 1 Aug 2019 4:44PM $0.011 $2.860 risen by 25,900%

676 - 700 of 1026 results

Page 28 of 42

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.